1. Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM)

   • Maria-Christina Kyrtsonis
   • Athanasia Mouzaki
   • Alice Maniatis

   Review 01 July 1999 Pages: 73 - 77

2. Cancer gene and immunotherapy: recent developments

   • Peter Jantscheff
   • Richard Herrmann
   • Christoph Rochlitz

   Review 01 July 1999 Pages: 78 - 85

3. Interleukin-10: a cytokine used by tumors to escape immunosurveillance

   • Flavio Salazar-Onfray

   Review 01 July 1999 Pages: 86 - 94

4. Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population

   • Adnan A Ezzat
   • Ezzeldin M Ibrahim
   • Robert K Stuart

   Original Paper 01 July 1999 Pages: 95 - 103

5. Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis

   • Morie A Gertz
   • Martha Q Lacy
   • Robert A Kyle

   Original Paper 01 July 1999 Pages: 104 - 109

6. Transforming growth factor-β and multidrug resistance in chronic lymphocytic leukemia

   • William R Friedenberg
   • Sherry A Salzman
   • James K Burmester

   Original Paper 01 July 1999 Pages: 110 - 118

7. Assessment ofall-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia

   • Nalini Swaminathan
   • Gabriel Lopez-Berestein
   • Stuart Rudikoff

   Original Paper 01 July 1999 Pages: 119 - 128

8. Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?

   • N Campanella
   • A Moraca
   • M Al-Refai

   Original Paper 01 July 1999 Pages: 129 - 133

9. Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney

   • Dilek Dinçol
   • Ali Arican
   • Abdülkadir Cengiz

   Case Report 01 July 1999 Pages: 134 - 138

10. Hepatosplenic candidiasis after neutropenic phase of acute leukaemia

    • M Čolović
    • V Lazarević
    • J Bila

    Case Report 01 July 1999 Pages: 139 - 142